Skip to main content

Hims & Hers Now Offering a Dual-Action Topical Hair Loss Treatment for Men

Harnessing the Powers of Finasteride and Minoxidil In A Single Spray, The Convenient Prescription Treatment Can Help Regrow Hair and Prevent Future Hair Loss

Hims & Hers, the multi-specialty telehealth platform that provides modern personalized health and wellness experiences to all consumers, is now offering men access to a convenient treatment for hair loss that combines two clinically-proven ingredients into a single spray. The Topical Finasteride & Minoxidil Spray is a pill-free prescription alternative to traditional oral finasteride treatment that provides effective support for male pattern hair loss. Featuring minoxidil 6% and finasteride 0.1%, the spray is available for appropriate customers with a prescription from a licensed medical professional through Hims & Hers platform, with consultations available at

The latest in a long list of high quality personalized wellness treatments available through the Hims & Hers telehealth platform, the combination of ingredients is specifically formulated to stop hair loss and regrow hair. Compared to oral finasteride that enters your bloodstream through taking pills, men can experience the benefits of finasteride treatment at lower concentrations to their bloodstream from the topical version through direct contact on their scalp. The dual-action spray works to block the production of the DHT hormones, which contribute to the damaging and closing of hair follicles. At the same time, the topical minoxidil helps to reactivate dormant hair follicles, increasing the length of the active growth phase and ultimately helping regrow hair.

“Hair loss will never be a one-size-fits-all experience, and neither should the way we treat it,” commented Hims & Hers Co-Founder and CEO Andrew Dudum. “We heard from our customers that they wanted more options to treat their hair loss—and in offering the two top-used ingredients that treat hair loss and growth in one really clean and simple-to-use form factor with the Topical Finasteride & Minoxidil Spray, men can experience the benefits of both these treatments in a convenient and efficient way.”

Finasteride treatments are commonly provided orally, but Hims & Hers customers have stated that they’d like to have an alternative to taking pills. In the same vein, the Hims & Hers team has heard from some customers that they’d like to have a drip-free, fine mist experience when applying a topical hair treatment – versus the dropper that some men find inconvenient for their hair type. To address these concerns, Hims & Hers is proud to now offer access to two clinically-proven ingredients in a less messy, convenient Topical Finasteride & Minoxidil Spray, a completely topical product that dries quickly with no drips or need for oral medication.

“With the addition of prescription Topical Finasteride & Minoxidil Spray, Hims is a leader in providing customizable offerings for hair loss in men,” said Hims & Hers’ Chief Medical Officer Dr. Patrick Carroll. “Hims’ suite of hair loss products can provide a high level of personalization for men who are seeking the optimal treatment for their own hair loss journey.”

The spray is available only with a prescription and requires a telehealth consultation with a medical professional through the Hims & Hers platform before beginning use.

For more details please visit

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit and


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.